Individual rare diseases impact only a very small fraction of people, but collectively they are estimated to affect over three million in South Africa. As we mark International Rare Disease Day on 28 February, Elna Schütz assesses the state of play with rare diseases in the country.
A cutting-edge, South African-led HIV vaccine trial built on decades of research recently kicked off in Cape Town. Elri Voigt unpacks what exactly is being studied, and how the resilience, tenacity and urgency of a group of dedicated South African researchers made it possible.
In South Africa, access to weight loss medicines like Ozempic and Mounjaro remains limited to those who can shell out a few thousand Rand a month. In the second article of a Spotlight special series, Catherine Tomlinson looks at the medical need for these medicines in the country and what it would take for government to provide them in the public sector.
District managers in South Africa’s public healthcare system currently have to juggle funding from multiple government budget lines, each with different strings attached. To improve district health services, we urgently need to simplify and integrate these funding flows, argues Russell Rensburg.
Spotlight has unveiled a new tuberculosis dashboard and graph generator. We hope this dashboard will help people get a clearer picture of the state of South Africa’s TB epidemic – an epidemic that still claims over 50 000 lives a year. It follows on the launch of a similar HIV dashboard last November.
In South Africa, as in many places, pharmaceutical companies are not free to change medicine prices as they wish. In his latest Inside The Box column, Dr Andy Gray unpacks how medicines prices are regulated in the country and considers how this regulatory framework might change.
From academic corridors to ministerial meetings and rural reaches, Leslie London has never shied away from speaking truth to power. Biénne Huisman speaks to the Emeritus Professor at the University of Cape Town, who, still in his bright signature shirt and trademark wry grin, continues to fight health inequity.
Bogus medical practitioners threaten the health of patients and undermines trust in doctors. The problem might be growing, but so is the fight against it. Elna Schütz reports.
The health department in the Western Cape is partnering with farms in the Cape Winelands to provide easier access to healthcare for farm workers. Sue Segar unpacks one such partnership and why it is a triple win for workers, businesses and the government.
Sales of weight loss medicines like Ozempic and Mounjaro have sky-rocketed in South Africa in recent years, although they remain too expensive for most people who might benefit from the jabs. In the first article of this Spotlight special series, Catherine Tomlinson tracks their remarkable rise and assesses when they will become more widely available here.
As HIV, TB and other treatments are updated in our public healthcare system, it is critical that healthcare workers and counsellors stay on top of the latest developments. One innovative programme makes use of short lessons delivered over WhatsApp to provide such training. Sue Segar reports.
From the limited rollout of a new HIV prevention jab to developments with new weight loss medicines, to high-stakes court cases relating to National Health Insurance (NHI), 2026 is set to be another tumultuous year in healthcare. Here are nine stories that Spotlight will keep a close eye on.
